Noonan Syndrome Cardiac and Growth Assessment

Assesses Noonan syndrome features including pulmonary stenosis severity, HCM risk, bleeding disorder (von Willebrand, platelet dysfunction), short stature SDS, and MEK/RAS pathway mutation for trametinib eligibility.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Assesses Noonan syndrome features including pulmonary stenosis severity, HCM risk, bleeding disorder (von Willebrand, platelet dysfunction), short stature SDS, and MEK/RAS pathway mutation for trametinib eligibility. Use the noonan syndrome score result to inform your calculation.

Frequently Asked Questions